CTOs on the Move


 
Wherever you are, exhale Therapeutic Air® to immediately access the ancient wellness art of aromatherapy. Unlike topical oils or household diffusers, MONQ® is enhanced for convenience in the modern age. Experience the most direct form of aromatherapy with MONQ Personal Diffuser.
  • Number of Employees: 100-250
  • Annual Revenue: $0-1 Million
  • www.monq.com
  • N/A
    Goodlettsville, TN USA N/A
  • Phone: 844.936.6667

Executives

Name Title Contact Details

Similar Companies

US Med

US Med, LLC is a Irving, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

BreezoMeter

BreezoMeter offers personalized air quality & pollen data as well as active fire alerts with worldwide coverage & accuracy down to the street level.

Prestige Medical

Prestige Medical is a Northridge, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Air Liquide Healthcare America Corporation

Air Liquide Healthcare America Corporation is a Houston, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

BioSig Technologies

BioSig Technologies, Inc. (OTCQB: BSGM) is a medical device company that is developing a proprietary technology platform to address an unmet technology need in the rapidly growing $4.6+ billion electrophysiology (EP) marketplace. Led by a proven management team, world-class Board of Directors and Scientific Advisory Board, Minneapolis-based BioSig Technologies is preparing to commercialize its PURE EP™ System. The PURE EP System is a surface electrocardiogram (ECG) and intracardiac multichannel recording and analysis system designed to assist electrophysiologists in making crucial clinical decisions in real-time by acquiring and displaying high-fidelity cardiac signal recordings even at undetectable levels (until now) with high accuracy to help identify appropriate catheter ablation targets - areas of tissue to destroy that create a heart rhythm disturbance (arrhythmia). BioSig`s main goal is to deliver technology to improve upon catheter ablation treatments for the prevalent and deadly arrhythmias, Atrial Fibrillation and Ventricular Tachycardia. PURE EP is an innovative platform, offering potential benefits over current technologies including increased accuracy, reduced noise and interference, clinical information previously not available and potential elimination of the need for repeat procedures. BioSig has partnered with Minnetronix on technology development and is working toward FDA 510(k) clearance for the PURE EP System.